Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Arbutus, Arch Biopartners, Chinese Academy of Sciences, Citrine Medicine, Corat, Cytocom, Everest Medicines, Meissa Vaccines, Qilu, RDIF, Redhill, Sesen.